TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34427233

Group type: COMPARATOR
Intervention: Human amniotic membrane
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Plasma-treated poly-?-caprolactone (pPCL) membrane
Number of subjects: 12
Study: 33049973

Group type: COMPARATOR
Intervention: LNS-S (sweetened SQ-LNS)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: LNS-U (unsweetened SQ-LNS)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Comparison of LNS-S and LNS-U
Number of subjects: 78
Study: 35271495

Group type: EXPERIMENTAL
Intervention: Intravenous vitamin C (ascorbic acid) administered three times a week for three months
Number of subjects: 32
Study: 32596937

Group type: EXPERIMENTAL
Intervention: Methods of skin protection for nasogastric tubes
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Methods of skin protection for endotracheal tubes
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Overall intervention
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Recruitment process
Number of subjects: 87
Study: 35659904

Group type: EXPERIMENTAL
Intervention: CYD-TDV vaccine
Number of subjects: 3983

Group type: EXPERIMENTAL
Intervention: OnSite IgG RDT
Number of subjects: 3983
Study: 35340961

Group type: EXPERIMENTAL
Intervention: 0.5% isobaric levobupivacaine with 75‐mg magnesium sulfate
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.5% hyperbaric bupivacaine with 75‐mg magnesium sulfate
Number of subjects: 60
Study: 32951292

Group type: EXPERIMENTAL
Intervention: Gracilaria algae cream 3%
Number of subjects: 30

Group type: COMPARATOR
Intervention: Clobetasol cream 0.05%
Number of subjects: 30
Study: 34006553

Group type: EXPERIMENTAL
Intervention: Participation in the Dutch Prospective Bladder Cancer Infrastructure (ProBCI) study, which includes extensive clinical data collection and patient-reported outcomes.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patient-reported outcomes collected every 4 months.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Informed consent for participation in questionnaires and molecular analyses.
Number of subjects: 0
Study: 32272513

Group type: EXPERIMENTAL
Intervention: Ceramide-containing moisturizing cream
Number of subjects: 0
Study: 36153168

Group type: EXPERIMENTAL
Intervention: Rotary instrumentation technique
Number of subjects: 90

Group type: COMPARATOR
Intervention: Manual instrumentation technique
Number of subjects: 90
Study: 33638278

Group type: EXPERIMENTAL
Intervention: Interactive online informational and peer support app for LARS
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Online peer support for LARS
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Age <65 years
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Minor/major LARS
Number of subjects: 69
Study: 32052694

Group type: EXPERIMENTAL
Intervention: Higher objective numeracy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher subjective numeracy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher math anxiety
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Math anxiety
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Education initiatives
Number of subjects: 0
Study: 34131999

Group type: EXPERIMENTAL
Intervention: Babu and Magon uterine closure technique
Number of subjects: 72

Group type: COMPARATOR
Intervention: Double-layer closure of the uterine incision
Number of subjects: 72
Study: 32145348

Group type: EXPERIMENTAL
Intervention: Catheter ablation
Number of subjects: 289831
Study: 35421696

Group type: EXPERIMENTAL
Intervention: Specific lower deep neck extensors (SLDNE) exercise program
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: General neck extensor (GNE) exercise program
Number of subjects: 43
Study: 34486701

Group type: EXPERIMENTAL
Intervention: Non-smokers (G1)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Smokers (G2)
Number of subjects: 61
Study: 35706490

Group type: EXPERIMENTAL
Intervention: 1000 mg intravenous ferric carboxymaltose (iron)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 32
Study: 32871552

Group type: EXPERIMENTAL
Intervention: Dynamic Stretching Warm-Up (DS-WU)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Plyometric Warm-Up (PL-WU)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Comparison of DS-WU and PL-WU
Number of subjects: 12
Study: 34448877

Group type: EXPERIMENTAL
Intervention: German-language Tinnitus Functional Index (TFI) for Germany
Number of subjects: 0

Group type: COMPARATOR
Intervention: German-language Tinnitus Functional Index (TFI) for Switzerland
Number of subjects: 0
Study: 33961310

Group type: EXPERIMENTAL
Intervention: Domagrozumab 5 mg/kg every 4 weeks
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Domagrozumab 20 mg/kg every 4 weeks
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Domagrozumab 40 mg/kg every 4 weeks
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Domagrozumab (after switching from 5 mg/kg to 40 mg/kg)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Extension study of domagrozumab
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 19
Study: 32538148

Group type: EXPERIMENTAL
Intervention: Hemocontrol hemodialysis (HHD)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Standard hemodialysis (SHD)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: HHD
Number of subjects: 29

Group type: COMPARATOR
Intervention: SHD
Number of subjects: 29
Study: 33964925

Group type: EXPERIMENTAL
Intervention: Intravenous lefamulin (150 mg every 12 h) for 5–7 days
Number of subjects: 1289

Group type: EXPERIMENTAL
Intervention: Oral lefamulin (600 mg every 12 h) for 5 days
Number of subjects: 1289

Group type: COMPARATOR
Intervention: Moxifloxacin (400 mg every 24 h) for 7 days
Number of subjects: 1289
Study: 33049929

Group type: EXPERIMENTAL
Intervention: Mankai-containing green Mediterranean/low-meat diet
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 294

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 294
Study: 35759733

Group type: EXPERIMENTAL
Intervention: Paclitaxel (P) 135 mg/m2 once every 28 days for 12 cycles
Number of subjects: 1157

Group type: EXPERIMENTAL
Intervention: Paclitaxel poliglumex (PP) 135 mg/m2 once every 28 days for 12 cycles
Number of subjects: 1157

Group type: COMPARATOR
Intervention: Surveillance (S)
Number of subjects: 1157
Study: 34530679

Group type: EXPERIMENTAL
Intervention: Developmentally adapted cognitive processing therapy (D‐CPT)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Wait-list condition with treatment advice (WL/TA)
Number of subjects: 43
Study: 32049627

Group type: EXPERIMENTAL
Intervention: Phosphate content in medications prescribed to HD patients
Number of subjects: 695759

Group type: EXPERIMENTAL
Intervention: Monitoring of medications containing phosphate
Number of subjects: 695759
Study: 36350907

Group type: EXPERIMENTAL
Intervention: Pachy‐100
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Pachy‐50
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Pachy‐0
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Pachy+50
Number of subjects: 12
Study: 33416291

Group type: EXPERIMENTAL
Intervention: Hypertensive disorders of pregnancy
Number of subjects: 119408

Group type: COMPARATOR
Intervention: No hypertensive disorders of pregnancy
Number of subjects: 119408
Study: 33136422

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Pain Education (EDU)
Number of subjects: 290
Study: 34969033

Group type: EXPERIMENTAL
Intervention: Treat-and-extend (T&E) regimen with intravitreal ranibizumab 0.5 mg
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Once-monthly to treat-and-extend (OM-T&E) regimen with intravitreal ranibizumab 0.5 mg
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Treat-and-extend (T&E) regimen
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Once-monthly to treat-and-extend (OM-T&E) regimen
Number of subjects: 139
Study: 33633081

Group type: EXPERIMENTAL
Intervention: Metronidazole treatment
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48

Group type: COMPARATOR
Intervention: D fragilis-negative children
Number of subjects: 48
Study: 36190330

Group type: EXPERIMENTAL
Intervention: Vitamin A specific activity in plasma (SAp)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Vitamin A specific activity in milk (SAm)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Combination of SAp and SAm
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Simulated FaS using SAp
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Simulated FaS using SAm
Number of subjects: 12
Study: 34538818

Group type: EXPERIMENTAL
Intervention: MPK + HYD
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: MPK + RIG
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: NMPK + HYD
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: NMPK + RIG
Number of subjects: 9
Study: 32965037

Group type: EXPERIMENTAL
Intervention: High-dose melatonin (4 mg for <40 kg; 8 mg for ≥40 kg)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Low-dose melatonin (1 mg for <40 kg; 2 mg for ≥40 kg)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: High-dose melatonin
Number of subjects: 84

Group type: COMPARATOR
Intervention: Low-dose melatonin
Number of subjects: 84
Study: 36700975

Group type: EXPERIMENTAL
Intervention: Pusen Uscope 3011
Number of subjects: 60

Group type: COMPARATOR
Intervention: LithoVue
Number of subjects: 60
Study: 34836393

Group type: EXPERIMENTAL
Intervention: 52 mL/day of EVOO (n = 50)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: DieTBra (n = 49)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: DieTBra + 52 mL/day of EVOO (n = 50)
Number of subjects: 149
Study: 32702660

Group type: EXPERIMENTAL
Intervention: Foam Rolling (FR)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Instrument-Assisted Soft Tissue Mobilization (IASTM)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 20
Study: 34822251

Group type: EXPERIMENTAL
Intervention: Topical anaesthetic (group A)
Number of subjects: 35

Group type: COMPARATOR
Intervention: No anaesthetic gel (group B)
Number of subjects: 35
Study: 33080415

Group type: EXPERIMENTAL
Intervention: Norepinephrine 4 μg/min
Number of subjects: 82

Group type: COMPARATOR
Intervention: Phenylephrine 50 μg/min
Number of subjects: 82
Study: 34218744

Group type: EXPERIMENTAL
Intervention: Tetrachoric correlation coefficient computed with Kirk's approach
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Analysis of variance estimator of the ICC
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intraclass correlation coefficient (ICC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Variance partition coefficient
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Median odds ratio
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Relative deviation of an ICC estimate to the theoretical maximum possible value
Number of subjects: 0
Study: 33203685

Group type: EXPERIMENTAL
Intervention: In-person follow-up visit
Number of subjects: 66

Group type: COMPARATOR
Intervention: Video call via mobile phone application
Number of subjects: 66
Study: 35281034

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (15 µg daily for 12 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin D2 (15 µg daily for 12 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (not specified dosage or duration)
Number of subjects: 0
Study: 33991392

Group type: EXPERIMENTAL
Intervention: Dentifrice containing turmeric and licorice extract
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control dentifrice
Number of subjects: 90
Study: 36259119

Group type: EXPERIMENTAL
Intervention: Early 2‐stage palatoplasty (ETS group)
Number of subjects: 86

Group type: COMPARATOR
Intervention: 1‐stage pushback palatoplasty (PB group)
Number of subjects: 86
Study: 33422476

Group type: EXPERIMENTAL
Intervention: Sandblasting before acid etching (SBE group)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Acid etching only (E group)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Initial bonding (IB group)
Number of subjects: 20
Study: 32109317

Group type: EXPERIMENTAL
Intervention: SRP + folic acid (SRP + F)
Number of subjects: 60

Group type: COMPARATOR
Intervention: SRP + placebo (SRP + P)
Number of subjects: 60
Study: 35140794

Group type: EXPERIMENTAL
Intervention: Continuous walking (CON) for 30 min, 3 days/week for 12 weeks
Number of subjects: 43

Group type: COMPARATOR
Intervention: Intermittent walking (INT) split into 3 sessions of 10 min with 1 min rest, 3 days/week for 12 weeks
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Both groups (CON and INT)
Number of subjects: 43
Study: 33290248

Group type: EXPERIMENTAL
Intervention: Metformin plus rosiglitazone
Number of subjects: 699

Group type: COMPARATOR
Intervention: Metformin alone
Number of subjects: 699

Group type: COMPARATOR
Intervention: Metformin plus intensive lifestyle intervention
Number of subjects: 699

Group type: COMPARATOR
Intervention: Routine diabetes care after discontinuation of rosiglitazone
Number of subjects: 699
Study: 32631074

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) 5 days/week
Number of subjects: 25

Group type: COMPARATOR
Intervention: Sham treatment (simulated microcurrent electrical nerve stimulation) 5 days/week
Number of subjects: 25
Study: 33070667

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diabetes Education (ED)
Number of subjects: 0
Study: 33747319

Group type: EXPERIMENTAL
Intervention: Nalbuphine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Ketorolac tromethamine (KT)
Number of subjects: 30
Study: 32660521

Group type: EXPERIMENTAL
Intervention: Low-volume preparation
Number of subjects: 25

Group type: COMPARATOR
Intervention: High-volume preparation
Number of subjects: 25

Group type: COMPARATOR
Intervention: Medium-volume preparation
Number of subjects: 25
Study: 36045651

Group type: EXPERIMENTAL
Intervention: Probiotics supplementation for 8 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo for 8 weeks
Number of subjects: 40
Study: 33916559

Group type: EXPERIMENTAL
Intervention: Cluster‐Based Energy Optimization with Mobile Sink (CEOMS) algorithm
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low Energy Adaptive Clustering Hierarchy Protocol (LEACH) architecture
Number of subjects: 0
Study: 34779576

Group type: EXPERIMENTAL
Intervention: Upadacitinib (UPA) 15 mg
Number of subjects: 338

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 338
Study: 33472997

Group type: EXPERIMENTAL
Intervention: Closed-loop target controlled infusion (CLTCI) of propofol
Number of subjects: 70

Group type: COMPARATOR
Intervention: Open-loop target controlled infusion (OLTCI) of propofol
Number of subjects: 70
Study: 33628012

Group type: EXPERIMENTAL
Intervention: Bilayer tablet of gemigliptin/rosuvastatin 50/20 mg
Number of subjects: 48

Group type: COMPARATOR
Intervention: Monolayer tablet of gemigliptin/rosuvastatin 50/20 mg
Number of subjects: 48
Study: 32186976

Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM) and dietary supplementation (vitamin D, iron, selenium)
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM)
Number of subjects: 350
Study: 36384478

Group type: EXPERIMENTAL
Intervention: Carer End of Life Planning Intervention (CELPI)
Number of subjects: 440
Study: 34686149

Group type: EXPERIMENTAL
Intervention: Protective sleeve group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 32383196

Group type: EXPERIMENTAL
Intervention: Articaine 4% with epinephrine 1:100,000
Number of subjects: 43

Group type: COMPARATOR
Intervention: Lidocaine 2% with epinephrine 1:100,000
Number of subjects: 43
Study: 33577389

Group type: COMPARATOR
Intervention: Over-minus therapy
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Over-minus therapy with inward decentration of spectacle glasses
Number of subjects: 64
Study: 32181503

Group type: EXPERIMENTAL
Intervention: NHL subclassification
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: Diffuse large B cell lymphoma
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: Chronic lymphocytic leukaemia
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: Burkitt lymphoma
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: Stage at diagnosis
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: HIV status
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: ECOG PS
Number of subjects: 516
Study: 35183346

Group type: EXPERIMENTAL
Intervention: Isoflurane general anaesthesia
Number of subjects: 60

Group type: COMPARATOR
Intervention: Resting wakefulness (Control)
Number of subjects: 60
Study: 34153105

Group type: EXPERIMENTAL
Intervention: Sleep
Number of subjects: 59

Group type: COMPARATOR
Intervention: Sleep Deprivation
Number of subjects: 59
Study: 36608969

Group type: EXPERIMENTAL
Intervention: Internet-based psychological intervention for PGD
Number of subjects: 0
Study: 34444341

Group type: EXPERIMENTAL
Intervention: Physical literacy-based intervention once weekly for 14 weeks
Number of subjects: 28

Group type: COMPARATOR
Intervention: Non-treated control group
Number of subjects: 28
Study: 32871529

Group type: EXPERIMENTAL
Intervention: Sustained glides
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Oscillatory glides
Number of subjects: 88

Group type: COMPARATOR
Intervention: Stiff shoulders
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: All conditions
Number of subjects: 88
Study: 33503173

Group type: EXPERIMENTAL
Intervention: Controlled-release morphine tablets combined with celecoxib
Number of subjects: 110

Group type: COMPARATOR
Intervention: Controlled-release morphine tablets alone (Control)
Number of subjects: 110
Study: 33582688

Group type: EXPERIMENTAL
Intervention: Laser Lithotripsy
Number of subjects: 90

Group type: COMPARATOR
Intervention: Pneumatic Lithotripsy
Number of subjects: 90
Study: 36205473

Group type: COMPARATOR
Intervention: Connection to Health (CTH)
Number of subjects: 734

Group type: EXPERIMENTAL
Intervention: Enhanced Engagement CTH (EE-CTH)
Number of subjects: 734
Study: 32960327

Group type: EXPERIMENTAL
Intervention: High-power Thulium Fibre Laser (TFL) with suction
Number of subjects: 54
Study: 32100681

Group type: EXPERIMENTAL
Intervention: Chlorinated drinking water and safe storage (W)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Upgraded sanitation (S)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Handwashing promotion (H)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined water, sanitation, and handwashing (WSH)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nutrition intervention including lipid‐based nutrient supplements
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined WSH plus nutrition (WSHN)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 0
Study: 33777422

Group type: EXPERIMENTAL
Intervention: Personalised physical activity consultations, pedometers, monthly messages via web-based application
Number of subjects: 232
Study: 35715966

Group type: EXPERIMENTAL
Intervention: School of Hard Talks intervention (8 hours of training in communication skills using motivational interviewing techniques)
Number of subjects: 62
Study: 34563169

Group type: EXPERIMENTAL
Intervention: Cabozantinib (60 mg daily, orally)
Number of subjects: 0
Study: 32193169

Group type: EXPERIMENTAL
Intervention: Disclaimer comments that critiqued the images as unrealistic
Number of subjects: 181

Group type: COMPARATOR
Intervention: Traditional comments that idealized the images
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Disclaimer comments
Number of subjects: 181

Group type: COMPARATOR
Intervention: Idealized Comment condition
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Both conditions
Number of subjects: 181
Study: 35329066

Group type: EXPERIMENTAL
Intervention: Aerobic exercise group (AerG)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Aerobic interval group (IntG)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Combined group (ComG)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 102
Study: 32005255

Group type: EXPERIMENTAL
Intervention: Increased availability of lower energy options (75% of menu options lower energy)
Number of subjects: 1743

Group type: COMPARATOR
Intervention: Menu energy labelling present
Number of subjects: 1743

Group type: COMPARATOR
Intervention: Menu energy labelling absent
Number of subjects: 1743

Group type: COMPARATOR
Intervention: Baseline availability of lower energy options (25% of menu options lower energy)
Number of subjects: 1743
Study: 33760976

Group type: EXPERIMENTAL
Intervention: Experimental group (156 subjects)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Test group (24 subjects)
Number of subjects: 180
Study: 33374947

Group type: EXPERIMENTAL
Intervention: 3 mg/kg/bm of caffeine (3COF)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: 6 mg/kg/bm of caffeine (6COF)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Decaffeinated coffee (PLA)
Number of subjects: 17
Study: 36174134

Group type: EXPERIMENTAL
Intervention: Transference-focused psychotherapy (TFP)
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Supportive psychodynamic therapy (SPT)
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Dialectical behavior therapy (DBT)
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Enhanced treatment as usual (eTAU)
Number of subjects: 194
Study: 32979042

Group type: EXPERIMENTAL
Intervention: Enhanced Patient Navigation program (PN+)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (PN)
Number of subjects: 120
Study: 35941895

Group type: EXPERIMENTAL
Intervention: Transarterial chemoembolization (TACE)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Modeling group (n = 120)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Prediction model
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Modeling group
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Validation group
Number of subjects: 160
Study: 33895220

Group type: EXPERIMENTAL
Intervention: Optimal PEEP (8.8 ± 2.4 cmH2O) with decremental titration after ARM
Number of subjects: 58

Group type: COMPARATOR
Intervention: Standard 5 cmH2O PEEP until the end of OLV
Number of subjects: 58
Study: 32515156

Group type: EXPERIMENTAL
Intervention: Vagus nerve stimulation (VNS)
Number of subjects: 9
Study: 33601948

Group type: EXPERIMENTAL
Intervention: Local infiltration analgesia (LIA) with 120 ml ropivacaine 0.2% plus epinephrine 0.5 µ/ml
Number of subjects: 63

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Local infiltration analgesia (LIA)
Number of subjects: 63